Loading...

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

BCR-ABL-mediated leukemias, either Chronic Myeloid Leukemia (CML) or Philadelphia positive Acute Lymphoblastic Leukemia (ALL), are the paradigm of targeted molecular therapy of cancer due to the impressive clinical responses obtained with BCR-ABL specific tyrosine kinase inhibitors (TKIs). However,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Hematol
Main Authors: Morotti, Alessandro, Carrà, Giovanna, Panuzzo, Cristina, Crivellaro, Sabrina, Taulli, Riccardo, Guerrasio, Angelo, Saglio, Giuseppe
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi Publishing Corporation 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710905/
https://ncbi.nlm.nih.gov/pubmed/26843864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/612567
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!